Bortrac 2 mg Injection
51,94$
14,45$
Bortrac 2 mg injection is a targeted anticancer therapy specifically designed to combat multiple myeloma and mantle cell lymphoma, two aggressive forms of cancer affecting the bone marrow and immune system respectively. By inhibiting the activity of certain proteins within cancer cells, Bortrac effectively disrupts their growth and leads to cell death, making it a critical component in the treatment regimen for these malignancies. It's essential to discuss potential side effects with your healthcare provider, as this medication may cause immune system suppression and other adverse reactions. Patients should be monitored regularly for any signs of infection or unusual symptoms during treatment. Bortrac offers hope for improved outcomes in individuals facing these challenging diagnoses, but adherence to prescribed therapy and follow-up appointments is crucial for safety and efficacy. Always consult with a healthcare professional before starting or stopping any medication to ensure it aligns with your health needs. Experience the potential benefits of Bortrac 2 mg injection as part of a comprehensive cancer treatment plan.
Quantité
Active Pharmaceutical Ingredient
Uses
• Bortrac 2 mg injection is primarily utilized in the treatment of multiple myeloma, a malignancy that impacts plasma cells in the bone marrow. These abnormal plasma cells disrupt the normal production of blood cells, leading to various health complications. By targeting these malignant cells, Bortrac 2 mg injection helps alleviate symptoms such as bone pain and fatigue. This treatment is essential for managing the disease and improving patients' overall quality of life.
• Another significant application of Bortrac 2 mg injection is in the management of mantle cell lymphoma, an aggressive form of non-Hodgkin lymphoma. This condition arises from B cells, which are crucial for the immune response. Patients with mantle cell lymphoma may experience symptoms like swollen lymph nodes and unexplained weight loss. Bortrac 2 mg injection plays a vital role in controlling the disease and addressing these debilitating symptoms.
• Bortrac 2 mg injection is also considered in combination therapy regimens for patients with relapsed or refractory multiple myeloma. In such cases, previous treatments may no longer be effective, necessitating a new approach to combat the disease. By incorporating Bortrac 2 mg injection into treatment plans, healthcare providers aim to enhance therapeutic outcomes. This approach can lead to significant improvements in disease management and patient well-being.
• Additionally, Bortrac 2 mg injection can be an important option for patients with relapsed mantle cell lymphoma who have not responded adequately to other treatments. The injection acts by inhibiting cancer cell growth, thus providing a new avenue for those facing limited options. This makes Bortrac 2 mg injection a critical component in the ongoing fight against aggressive lymphomas. It is designed to help restore balance in patients' health and improve their response to therapy.
Benefits
Bortrac 2 mg Injection contains the active substance bortezomib, also called a ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, it can kill cancer cells. Bortrac 2 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in patients 18 years or older. It may be used alone or together with other medicines.
Side Effects
Like all medications, Bortrac Injection can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Burning feeling of skin
• Stomach Pain
• Insomnia
• Dehydration
• Pneumonia
• High fever
Common Side Effects
• High Blood Pressure
• Tiredness
• Cough
• Chest Tightness
• Feet Swelling
How To Use
Bortrac 2 mg is administered intravenously or subcutenously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Bortrac 2 mg Injection. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you: before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you if consumption of alcohol is safe or not.
• Kidney: Bortrac 2 mg Vial should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bortrac 2 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to adjust the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Bortrac 2 mg is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Bortrac Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bortezomib Injection 2 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to adjust the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Bortrac Injection. Bortrac 2 mg Injection is generally considered unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bortrac 2 mg Vial during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Bortrac 2 mg Vial will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Bortrac 2 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.